Jan Skvarka

Affiliations

  • Director at Zentalis Pharmaceuticals Inc. (ZNTL), 2025-06-18
  • at Monte Rosa Therapeutics Inc. (GLUE), 2025-06-16
  • President And Ceo at Trillium Therapeutics Inc. (TRIL), 2021-11-19
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ZNTL $1.72 60,000 $103,446.00 149,551 2025-01-31 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ZNTL $25.05 5,000 $125,237.50 47,970 2023-09-11 Filing
TRIL $9.24 23,802 $219,880.50 0 2021-05-12 Filing
TRIL $9.20 106,698 $981,802.99 0 2021-05-11 Filing
TRIL $15.03 19,581 $294,278.93 0 2021-01-14 Filing
TRIL $15.04 5,419 $81,507.72 0 2021-01-13 Filing